Vox Sanguinis

杂志介绍

Vox Sanguinis杂志介绍

《Vox Sanguinis》是一本以English为主的未开放获取国际优秀期刊，中文名称血之声，本刊主要出版、报道医学-HEMATOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.8，最新CiteScore 指数为4.4。

本刊近期中国学者发表的论文主要有：

• Information technology improves the quality of transfusion practice in China

  Author: Xu, Gui-Ping; Wu, Li-Fang; Xu, Xiao-Min; Li, Jing-Jing; Gao, Qi; Lu, Hua

• First donor haemovigilance system at a national level in China: Establishment and improvement

  Author: Yang, Junhong; Fan, Dinrong; Xie, Dongfu; Guo, Xiaojie; Zhu, Wenqing; He, Tao; Huang, Xia

• Application of droplet digital PCR combined with TaqMan real-time PCR in Dombrock blood group genotyping in Northwest China

  Author: Li, Zhuolin; Wang, Yufeng; Sun, Mao; Chen, Tangdong; Wu, Yuanming; Chen, Kun

• International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

  Author: Storry JR¹, Clausen FB², Castilho L³, Chen Q⁴, Daniels G⁵, Denomme G⁶, Flegel WA⁷, Gassner C⁸, de Haas M⁹, Hyland C¹⁰, Yanli J¹¹, Keller M¹², Lomas-Francis C¹³, Nogues N¹⁴, Olsson ML^1,15, Peyrard T¹⁶, van der Schoot E¹⁷, Tani Y¹⁸, Thornton N¹⁹, Wagner F²⁰, Weinstock C²¹, Wendel S²², Westhoff C¹³, Yahalom V²³.

英文介绍

Vox Sanguinis杂志英文介绍

Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:

1) Transfusion - Transmitted Disease and its Prevention:

Identification and epidemiology of infectious agents transmissible by blood;

Bacterial contamination of blood components;

Donor recruitment and selection methods;

Pathogen inactivation.

2) Blood Component Collection and Production:

Blood collection methods and devices (including apheresis);

Plasma fractionation techniques and plasma derivatives;

Preparation of labile blood components;

Inventory management;

Hematopoietic progenitor cell collection and storage;

Collection and storage of tissues;

Quality management and good manufacturing practice;

Automation and information technology.

3) Transfusion Medicine and New Therapies:

Transfusion thresholds and audits;

Haemovigilance;

Clinical trials regarding appropriate haemotherapy;

Non-infectious adverse affects of transfusion;

Therapeutic apheresis;

Support of transplant patients;

Gene therapy and immunotherapy.

4) Immunohaematology and Immunogenetics:

Autoimmunity in haematology;

Alloimmunity of blood;

Pre-transfusion testing;

Immunodiagnostics;

Immunobiology;

Complement in immunohaematology;

Blood typing reagents;

Genetic markers of blood cells and serum proteins: polymorphisms and function;

Genetic markers and disease;

Parentage testing and forensic immunohaematology.

5) Cellular Therapy:

Cell-based therapies;

Stem cell sources;

Stem cell processing and storage;

Stem cell products;

Stem cell plasticity;

Regenerative medicine with cells;

Cellular immunotherapy;

Molecular therapy;

Gene therapy.